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12 Methanol is an attractive alternative non-food feedstock for industrial fermentations that can be used 
13 instead of sugar-based raw materials. Here, the thermophilic and methylotrophic bacterium Bacillus 
14 methanolicus MGA3 was metabolically engineered to produce the platform chemical (R)-acetoin from 
15 methanol at 50 °C. Three different heterologous alsSD/budAB operons, each encoding acetolactate synthase 
16 and acetolactate decarboxylase, were functionally expressed under control of an inducible promoter in 
17 B. methanolicus MGA3, resulting in up to 0.26 ± 0.04 g/L of (R)-acetoin titer in shake flask cultivations. To 
18 further improve acetoin production, a total of six different genes or operons were expressed in the acetoin 
19 producing strains to increase supply of the acetoin precursor pyruvate. In particular, expression of a gene 
20 coding for malic enzyme from Geobacillus stearothermophilus in combination with the isocitrate lyase gene 
21 from B. methanolicus MGA3 increased acetoin titers 1.6-fold up to 0.42 ± 0.01 g/L which corresponds to 
22 0.07 g/g methanol. This resulted in an MGA3 strain overproducing 4 recombinant enzymes in total from 
23 two different plasmids with two distinct antibiotics resistance markers, demonstrating the increased 
24 complexity of metabolic engineering allowed by newly developed genetic tools for this organism. To our 
25 knowledge, this is the first demonstration of microbial production of acetoin from methanol.
26 Introduction
27 Production of bulk chemicals in environmentally friendly biological processes is an area of 
28 increasing interest. For example, ketone compounds such as acetoin can replace petroleum-derived 
29 compounds which are in high demand as platform chemicals. Acetoin can be used as a food additive, 
30 chemical synthesis precursor and as a promoter of plant growth and was highlighted as a second 
31 tier building block in a 2004 report by the United States Department of Energy. 1–4 Estimates of 
32 global acetoin consumption in food products alone put the number at several thousand tons 
33 annually, with prices in the $30-50 per kilogram range. 2
34 Acetoin is naturally produced in microbial fermentation processes and it has been suggested that 
35 production of acetoin and the closely related 2,3-butanediol help to prevent acidification of the 
36 cytoplasm during excessive organic acid production. 5 Biosynthesis of acetoin has been achieved in 
37 many species lacking native enzymes by heterologous overexpression of genes coding for 
38 acetolactate synthase (alsS) and acetolactate decarboxylase (alsD) from native acetoin producers, 
39 f. ex. Bacillus subtilis. 6 Acetolactate synthase (AlsS) catalyzes condensation of two molecules of 










































































40 pyruvate to acetolactate, which is then decarboxylated in the reaction catalyzed by acetolactate 
41 decarboxylase (AlsD) to acetoin. 7 (R)-Acetoin is currently produced in high titers in microbial 
42 fermentation by species such as Serratia marcescens (S. marcescens; 75,2 g/L acetoin in fed-batch 
43 culture) and B. subtilis (53.9 g/L acetoin in batch culture), and enzymatic characterization of 
44 acetolactate decarboxylase from B. subtilis has shown that it is enantioselective for (R)-acetoin 
45 synthesis. 5–9 The risk group classification of acetoin producing strains must be considered and 
46 while products from B. subtilis are generally recognized as safe (GRAS), S. marcescens is classified 
47 into risk group 2 which can cause complications and additional costs in production processes. 10,11    
48 These processes rely on sugars as carbon sources, leading to undesirable competition with food and 
49 feed industry, and indirectly to increasing prices of sugar 12. Finding substitutes to refined sugars as 
50 raw materials for fermentation processes is an area of active research, and alternative carbon 
51 sources such as arabinose, xylose, cellulose, hemicellulose, lignocellulose and seaweed have been 
52 used in sustainable acetoin production. 13–16 However, the sugar-based carbon sources have some 
53 limitation for use as feedstock in bio-industries as they compete with agriculture for use of fertile 
54 land resulting in higher costs, strict rules and price regulations. 17 Furthermore, use of lignocellulose 
55 may cause technical bottlenecks for bioproduction. 
56 Methanol is a suitable substitute for feedstock currently used in biotechnological processes, and can 
57 be utilized by methylotrophs for biomass production and respiration. 12 Methanol occurs naturally 
58 in the environment and can be synthesized in large scales from natural gas, biomass, CO2, coal and 
59 oil, which decouples its price from the agricultural market and assures its renewability. 18–21 
60 Methanol has also been receiving increased attention as a potential replacement for fossil fuels, and 
61 Patterson et al. (2019) recently proposed a radical idea for renewable production of methanol based 
62 on CO2 and H2 extracted from sea water, powered by renewable electricity such as floating solar 
63 panels or offshore wind turbines. 22 Methanol production on this scale would make fermentation 
64 processes using methylotrophs a truly attractive replacement for conventional sugar-based 
65 fermentation. As a result, methanol is a promising raw material for bio-based production of value-
66 added compounds such as acetoin. 
67 The pursuit of biologically sourced chemistry which can efficiently and selectively introduce carbon 
68 bonds between C1 compounds is critical. Current methods such as the Guerbet reaction can convert 
69 short-chain alcohols to longer chain alcohols by addition of methanol, but is not able to form C-C 










































































70 bonds with methanol as the only substrate. 23 It has been shown that methanol can be converted 
71 into longer chain alcohols in the presence of metal acetylides, but the process is non-catalytic and 
72 therefore requires a constant supply of metal acetylides. 24 Another approach to producing higher 
73 order alcohols from methanol used a cell free biocatalytic system containing purified enzymes to 
74 convert methanol into ethanol and n-butanol. 25 While this strategy could in theory match the 
75 flexibility of cell-based systems, it depends on costly, purified enzymes for new production 
76 pathways, which could be a limiting factor for many target compounds. Whole cell biocatalysis can 
77 be used for production of methylated organic compounds, which are currently synthesized by use 
78 of Grignard reagents, diazomethane, methyl iodine, dimethylcarbonate or methyl sulfate, most of 
79 which are toxic, flammable or explosive. 26–28 Fermentative methylamination using 
80 monomethylamine in sugar-based processes led to N-methylated amino acids, however, methanol 
81 only contributed to a minor part of the product e.g. sarcosine or N-methyl-L-glutamate and no C-C 
82 bond was formed. 29,30 This means that the most adaptable strategy for conversion of methanol into 
83 higher order alcohols and other multi-carbon compounds is therefore likely through genetic 
84 engineering of methylotrophic hosts, such as the one presented in our study.The Gram-positive, 
85 thermophilic methylotroph Bacillus methanolicus MGA3 is able to utilize methanol as a sole energy 
86 and carbon source during fermentation, it is, therefore, a promising candidate as a production 
87 workhorse in the methanol economy. 31 Due to its thermophilic nature, B. methanolicus grows 
88 optimally at 50 °C. This is a desired feature since its methylotrophic metabolism is highly oxygen 
89 intensive and exothermic and the elevated growth temperature leads to a reduction in cooling 
90 requirements for large scale fermentations which translates to lower energy consumption as 
91 compared to the traditional processes with mesophiles such as E. coli.
92 B. methanolicus MGA3 has previously been used to produce amino acids and amino acid derivatives 
93 from methanol. 32–34 These compounds have in common that they are either naturally overproduced 
94 in B. methanolicus or are direct derivatives of naturally overproduced amino acids, and their 
95 synthesis was established through heterologous overexpression of suitable biosynthetic pathways. 
96 Significant progress has been made in the utilization of B. methanolicus MGA3 as a host for industrial 
97 production processes in recent years, f. ex. new genetic tools have been developed such as a theta 
98 replicating plasmid backbone (pHCMC04 derivative), a xylose inducible promoter and the discovery 
99 of compatible plasmids. 35 The use of a xylose inducible expression system enabled exploiting the 










































































100 regulated nature of the promoter for transient gene expression, potentially avoiding toxic 
101 accumulation of reaction intermediates during biomass accumulation. The possibility of 
102 introducing two separate plasmids into the same cell has expanded the possible complexity of 
103 genetic engineering projects by accommodating greater numbers of overexpressed genes or 
104 pathways in a stable fashion. Additionally, new insights into the transcriptome, proteome and 
105 metabolome of B. methanolicus have opened up the possibility of more targeted genetic engineering 
106 approaches by exploiting naturally abundant metabolites or enzymes. 36–39 
107 In this study, we have used a methylotrophic host in order to establish methanol-based production 
108 of acetoin. We identified the alsSD operon from B. subtilis, Bacillus licheniformis or Enterobacter 
109 cloacae as suitable candidates to enable (R)-acetoin overproduction by B. methanolicus MGA3. 
110 B. subtilis and B. licheniformis have successfully been engineered for acetoin production, while 
111 E. cloacae has been shown to be a natural overproducer of acetoin. 6,13,40,41 The enzyme encoded by 
112 operon, acetolactate synthase and acetolactate decarboxylase, convert pyruvate into acetoin 
113 through acetolactate. Overexpression of the alsSD operon from B. subtilis in B. methanolicus MGA3 
114 resulted in proof-of-concept for acetoin production from methanol. To improve acetoin titers, we 
115 overexpressed genes coding for enzymes involved in pyruvate production reactions in order to 
116 increase the cytoplasmic pyruvate availability for the acetolactate synthase reaction. In order to do 
117 so, we selected isocitrate lyase and melic enzyme for overexpression, as shown in Figure 1. 42 This 
118 improved acetoin titers compared to the control strain to final titer of 0.42 ± 0.01 g/L. 
119 Materials and Methods
120 Bacterial strains, plasmids, molecular cloning and growth conditions
121 Bacterial strains and plasmids constructed and used in this study are listed in Table 1. All cloning 
122 work was performed in Escherichia coli DH5α. E. coli cells were made chemically competent by 
123 using the rubidium-chloride method. 43 Molecular cloning techniques were performed as detailed 
124 in Sambrook and Russel (2001). 44 Recombinant DNA was assembled in vitro using Gibson assembly 
125 as described by Gibson et al. (2009). 45 DNA sequencing was done by Eurofins Genomics and 
126 isolation of plasmid DNA was done with the use of Monarch Plasmid Miniprep Kit (New England 
127 Biolabs, T1010L).










































































128 Genomic DNA from B. subtilis 168, B. licheniformis MW3, B. methanolicus MGA3, 
129 G. sterarothermophilus 10, Lactococcus lactis ssp. lactis IL1403 and C. glutamicum ATCC13032 was 
130 isolated by use of a modified version of method presented by Eikmanns et al. (1994). 46 PCR 
131 products were amplified using Cloneamp HiFi PCR Premix (Takara, 639298) and purified using 
132 QIAquick PCR Purification kit (28106) from Qiagen. DNA fragments were separated using 0.8 % 
133 SeaKem LE agarose gels (Lonza, 50004) and isolated using QIAquick Gel Extraction Kit (Qiagen, 
134 28706). All primers were purchased from Sigma Aldrich. B. methanolicus MGA3 was made 
135 electrocompetent and transformed by electroporation as described by Jakobsen et al. (2006). 47
136 Shake flask cultivations with recombinant B. methanolicus MGA3 strains were cultivated in 250 mL 
137 baffled shake flasks at 50 °C and 200 RPM in 40 mL MVcM medium containing 200 mM methanol as 
138 described previously (Jacobsen et al 2006). 48 Antibiotics, 5 µg/mL chloramphenicol and 25 µg/mL 
139 kanamycin were supplemented as necessary.
140 For C. glutamicum growth experiments, pre-cultivation was performed first in brain heart infusion 
141 (BHI, ROTH) liquid medium for 8 hours and cells were transferred to CGXII medium with 1 % (w/v) 
142 glucose and 0.5 % potassium acetate for overnight cultivation. C. glutamicum main cultures in 
143 BioLector (m2p-labs, Baesweiler, Germany) were cultivated in Flowerplates at 1000 rpm, 85 % 
144 humidity, 30 °C and backscatter gain 20. Inoculation of CGXII medium was performed to an initial 
145 OD600 of 1 and 1 % (w/v) glucose and/or 0.5 %/1 % potassium acetate were used as carbon 
146 source(s). Isopropyl β-D-1-thiogalactopyranoside (IPTG) (1 mM) was supplemented for induction.
147 Vector constructions
148 Plasmid pBV2xp was constructed based on pBV2mp. The mdh promoter was removed by digestion 
149 with KpnI and XbaI and exchanged with the xylose inducible system which was amplified from 
150 pTH1xp by using the primers xp-pBV2_fw and xp-pBV2_rv. 
151 The three different acetoin biosynthetic operons were cloned into the pBV2xp plasmid under 
152 control of the xylose inducible xp promoter originating from Bacillus megaterium. 35 The six 
153 different genes/operons (mae, odx, pyk-pckA, citM, aceA) were cloned individually or in pairs into 
154 the pTH1mp plasmid under control of the strong and constitutive methanol dehydrogenase 
155 promoter Pmdh. 31 The pTH1mp and pBV2xp plasmids are based on two different and compatible 
156 replicons. 35 More specifically, pBV2xp was digested with SacI and BamHI or BspTI, the pTH1mp 
157 and pMI2mp plasmids were digested with PciI and BamHI, and the pTH1mp-maeGs was cut with 










































































158 EcoRI. Plasmid pEC-XT99A was digested with BamHI. Digestion was followed by separation by 
159 agarose gel electrophoresis and purification of the vector backbone fragments for cloning. 
160 The alsSD/budA encoding regions of B. subtilis 168 (Accession numbers: AQR83639.1 and 
161 AQR83638.1) and B. lichenformis MW3 (Accession numbers: AAU42663.1 and AAU42662.1) were 
162 PCR amplified from genomic DNA by using the primer pairs alsSD B. subtilis FW and alsSD B. subtilis 
163 RV and alsSD B. licheniformis FW and alsSD B. licheniformis RV, respectively. The budAB encoding 
164 region of E. cloacae (Accession numbers: AFM58913.1 and AFM58914.1) was PCR amplified from 
165 the plasmid pET-RABC by using the primer pair budAB E. cloacae FW and budAB E. cloacae RV.
166 The citM gene from L. lactis (Accession number: FV54_06325), malic enzyme gene (mae) from 
167 G. stearothermophilus (Accession number: GS458_1402), malic enzyme gene (mae) from 
168 B. licheniformis (Accession number: CXG95_00500), odx gene from C. glutamicum (Accession 
169 number: CYL77_06515), and the pyk (Accession number: BMMGA3_13080), pckA (Accession 
170 number: BMMGA3_13575), aceA (Accession number: BMMGA3_01745) genes/operon from 
171 B. methanolicus were amplified from genomic DNA using primer pairs AC03/AC04, AC11/AC12, 
172 AC05/AC06, AC01/AC02, AC09/AC10, AC07/AC08, and AC13/AC14, respectively. For construction 
173 of pBV2xp-aceBA and pEC-XT99A-aceBA, the aceBA (Accession number: BMMGA3_01745 and 
174 BMMGA3_01750, respectively) operon from B. methanolicus was amplified using primers 
175 aceB_pBx_fw/aceA_pBx_rv and aceB_pEc_fw/aceA_pEc_rv, respectively.
176 100 ng of the linearized and purified pBV2mp, pBV2xp, pTH1mp, pMI2mp, pTH1mp-maeGs vector 
177 fragments were then mixed in a 1:3 molar ratio with the different PCR fragments and assembled at 
178 50 °C using isothermal Gibson assembly, resulting in plasmids pBV2xp, pBV2xp-alsSDBs, pBV2xp-
179 alsSDBl, pBVxp-budABEc, pBV2xp-aceBABm, pEC-XT99A-aceBABm, pMI2mp-citMLl, pTH1mp-maeGs, 
180 pTH1mp-maeBl, pTH1mp-odxCg, pTH1mp-pckA-pykBm and pTH1mp-maeGs-aceABm. All constructed 
181 plasmids were verified with DNA sequencing before transformation to B. methanolicus MGA3 or 
182 C. glutamicum MH20-22b strains. PCR primers are listed in Table 1. 
183 Evaluation of acetoin toxicity on B. methanolicus
184 B. methanolicus MGA3 cells were inoculated from a glycerol stock into pre-warmed MVcMY medium 
185 supplemented with 200 mM methanol, and incubated at 50 °C, 200 RPM for 16-18 hours. 25 mL pre-warmed 
186 MVcM medium supplemented with racemic acetoin (0, 0.5, 1.0, 5.0, 7.5, 10.0, 15.0, 25.0 or 50.0 g/L), and 
187 methanol (200 mM) was inoculated with pre-culture to a starting OD600 of 0.2 and incubated at 50 °C, 200 










































































188 RPM. OD600 was measured every 2 hours after inoculation for 10 hours, with a final measurement 24 hours 
189 after inoculation. All cultures were grown in triplicates. IC50 for acetoin was determined by plotting the 
190 growth rates of the MGA3 cultures against their acetoin concentrations and estimating the acetoin 
191 concentration which halved the maximal growth rate achieved in this experiment (without acetoin).
192 Preparation of cell free extracts and coupled α-acetolactate synthase and α-acetolactate 
193 decarboxylase enzyme activity assay
194 Recombinant B. methanolicus strains were inoculated to OD600 = 0.2 in 40 mL pre-warmed (50 °C) 
195 MvCM medium and induced by adding xylose to a final concentration of 1 % at OD600 = 0.4. At OD600 
196 = 0.8, 20 mL of the culture was collected and centrifuged at 4000 x g for 10 minutes at 4° C. The cells 
197 were washed two times with ice cold phosphate buffer (61.5 mM K2HPO4, 38.5 mM KH2PO4, 10 mM 
198 MgCl2, pH 7.0) before storing at -80 °C. The cells were thawed by adding 1 mL ice cold phosphate 
199 buffer and incubating in an ice bath. The thawed cell suspension was then lysed by sonication, while 
200 still in the ice bath, using a Fisherbrand Sonic Dismembrator (FB-505) with 40 % amplitude and 2 
201 seconds pulse cycle for totally 5 minutes. The lysate was centrifuged for 1 hour at 14000 x g at 4 °C, 
202 and supernatant was finally collected as cell free crude extract. The protein concentration of the 
203 samples was determined by use of a Bradford assay using bovine serum albumin as the standard.
204 The assay for coupled α-acetolactate synthase and α-acetolactate decarboxylase activities was 
205 adapted from Wiegeshoff and Marahiel (2007). 49 The reaction was started by mixing 50 µL of crude 
206 cell extract with 283 µL of pre-warmed (50 °C) assay reaction mix containing pH 7.0 phosphate 
207 buffer, 0.2 mM TPP (Sigma), and 10 mM of the substrate Na-pyruvate (Sigma). The reaction was 
208 terminated after 5, 10 and 20 minutes as described in McDevitt (2009). 50 The acetoin concentration 
209 was determined with the Voges-Proskauer reaction, measured spectrophotometrically at 530 nm 
210 (SpectraMax Plus 384 Microplate Reader, Molecular Devices LLC.), as described by McDevitt (2009). 
211 50 Acetoin standard was purchased from Alfa Aesar. 1 U of activity corresponds to 1 µM of acetoin 
212 formed per min.
213 Preparation of cell free extracts and isocitrate lyase enzyme activity assay
214 Recombinant B. methanolicus strains were harvested after overnight cultivation in 50 mL pre-
215 warmed (50 °C) MvCM medium supplemented with 0.25 g/L yeast extract, 200 mM methanol and 
216 induced with 5 g/L xylose. The cells were centrifuged at 4000 x g for 10 minutes at 4 °C and the 
217 pellet was resuspended in 50 mM morpholinopropanesulfonic acid (MOPS) buffer (pH 7.3). After 










































































218 sonication with a Hielscher Ultrasound Processor instrument (UP220S, Berlin, Germany; cycle: 0.5, 
219 amplitude %: 60) for 9 minutes the lysate was centrifuged for 90 minutes at 20000 x g at 4 °C and 
220 the supernatant was used for the isocitrate lyase assay. The protein concentration was determined 
221 by using the Bradford method. The isocitrate lyase assay was performed by the method of 
222 Reinscheid et al. (1994) at 30 °C and 50 °C. In the cleavage reaction, 1 U of activity corresponds to 
223 1 µM of glyoxylate formed per min. 51
224 Detection of acetoin production by recombinant B. methanolicus strains
225 Supernatants from the recombinant B. methanolicus cultures were collected by centrifugation at 
226 13000 x g, at 23 °C for 15 minutes. 30 µL of trichloroacetic acid was added to 200 µL supernatant to 
227 precipitate proteins. The precipitate was filtered through 0.45 um filters (Acro LC 13 mm, 0.45 µm) 
228 before being analyzed by HPLC. HPLC analysis was done on a Waters e2695 separation module 
229 using a Symmetry C18 column (4.6 mm x 75 mm). Detection of acetoin was performed using a 
230 Waters 2489 UV/Vis detector at 190 nm. The mobile phase composition was 30 mM H3PO4, pH 2.5 
231 (pH adjusted with 10 M NaOH):acetonitrile (95:5), with a flow rate of 0.9 mL/min at 30 °C. The 
232 sample chamber was kept at 4 °C, and the injection volume was set to 2.5 µL. Retention time of 
233 acetoin under these conditions was around 1.5 minutes.
234 Results and discussion
235 Evaluation of B. methanolicus MGA3 as a host for acetoin production
236 To evaluate the suitability of B. methanolicus MGA3 as a host for acetoin production we investigated 
237 whether B. methanolicus naturally produces acetoin, potential toxicity effects of acetoin on cell 
238 physiology and whether acetoin is degraded by B. methanolicus.
239 First, an investigation of the genome sequence of B. methanolicus MGA3 revealed two genes, ilvH 
240 and ilvB, encoding the small and large subunit of acetolactate synthase which catalyzes the 
241 conversion of two molecules of pyruvate to one molecule of acetolactate. This particular enzyme is 
242 an entry point into the native branched chain amino acid synthesis pathway, and is likely under 
243 metabolic regulation by valine (as observed in other species), and so heterologous alternatives were 
244 needed for overexpression. 52 No native genes were found that would provide MGA3 with the ability 
245 of converting acetolactate to acetoin, despite the finding that small quantities of acetoin were 
246 produced by wildtype MGA3. This could result from spontaneous decarboxylation of acetolactate, 










































































247 produced by native acetolactate synthase encoded by ilvH and ilvB, to acetoin, which has been 
248 observed previously. 53 
249 Next, in order to investigate the suitability of B. methanolicus MGA3 as a host for acetoin production 
250 we analyzed its tolerance to acetoin. An initial experiment was set up to assay tolerance of 
251 B. methanolicus MGA3 to acetoin by growing B. methanolicus MGA3 cultures in minimal medium 
252 with 200 mM methanol as a carbon source and increasing concentrations of acetoin. The growth 
253 rates of the cultures were monitored by measuring OD600 every two hours over the course of 10 
254 hours, and finally after 23 hours, and the growth rates at increasing concentrations of acetoin were 
255 compared, resulting in Figure 2. This revealed that the IC50 of acetoin in B. methanolicus MGA3 was 
256 26 g/L (293 mM), at which point the growth rate was half (0.20 h-1) of the maximal growth rate 
257 (0.39 h-1). However, it must be noted that the acetoin used in this experiment was delivered as a 
258 dimer, which produces a racemic mix of acetoin upon monomerization by melting. 54 For that 
259 reason, an estimate for the IC50 of either (S)- or (R)-acetoin in B. methanolicus is in the range of 13 - 
260 26 g/L.
261 Finally, once we had analyzed the influence of acetoin supplementation on the growth of 
262 B. methanolicus MGA3, we proceeded to investigate if B. methanolicus MGA3 was able to degrade 
263 acetoin. Fresh MVcM with 200 mM methanol, MVcM with 50 mM acetoin or MVcM with 200 mM 
264 methanol and 50 mM acetoin was inoculated with the overnight cultures of B. methanolicus MGA3. 
265 The growth of these cultures was monitored by OD600 measurements, and supernatants were 
266 sampled to measure acetoin concentrations. After 24 hours no growth was detected in the culture 
267 containing minimal medium with 50 mM acetoin, while the culture with MVcM supplemented with 
268 methanol and acetoin showed the expected growth rates. Additionally, analysis of the supernatants 
269 of MGA3 grown in MVcM with methanol and acetoin showed that the acetoin concentration in the 
270 medium changed from 6.2 g/L ± 0.15 to 5.3 ± 0.6 g/L over the course of 24 hours (data not shown). 
271 This indicates that B. methanolicus MGA3 seems to be able to degrade acetoin over long time 
272 periods, however, it does not utilize it as a carbon source for growth. In order to understand the 
273 metabolic background of this observation, we inspected the genome of B. methanolicus in search of 
274 genes coding for putative 2,3-butanediol dehydrogenases, but none were identified. A control 
275 experiment was performed where crude extracts of wild type B. methanolicus cells were tested for 
276 2,3-butanediol dehydrogenase activity, and we could detect low background activity likely due to 










































































277 (a) promiscuous alcohol dehydrogenase enzyme(s) (0.05 ± 0.04 U/mg; data not shown) which could 
278 explain the slow degradation of acetoin observed previously.
279 Heterologous expression of α-acetolactate synthase and α-acetolactate decarboxylase and 
280 production of acetoin in B. methanolicus 
281 In this study, we have genetically engineered B. methanolicus MGA3 for acetoin biosynthesis. Three 
282 alsSD/budAB operons from different species were selected for controlled heterologous 
283 overexpression in B. methanolicus MGA3 to establish production of acetoin. The sources of 
284 alsSD/budAB operons were selected based on literature review of effective acetoin producers, with 
285 a preference for closely related species such as other Bacilli. As result, three alsSD/budAB operons 
286 from Bacillus subtilis, Bacillus licheniformis and Enterobacter cloacae were cloned into a pBV2 
287 backbone under the control of the xylose inducible promoter (xp) from Bacillus megaterium and 
288 transformed into B. methanolicus MGA3. 
289 To analyze the constructed strains, we first performed coupled α-acetolactate synthase and α-
290 acetolactate decarboxylase enzyme assays to evaluate the activity of the enzymes involved in the 
291 acetoin biosynthesis pathway. The production and control strains, MGA3 acetBs, MGA3 acetBl, MGA3 
292 acetEc and MGA3 pBV2xp, were cultivated in shake flasks with minimal medium supplemented with 
293 0.25 g/L yeast extract, 200 mM methanol and 1 % xylose and harvested at OD600 ≥ 0.8. The cell 
294 material was disrupted by sonication and the enzyme activity was assayed as described by Gerwick 
295 et al. (1994), with slight modifications. 55 Due to the fact, that B. methanolicus MGA3 is typically 
296 cultivated at 50 °C, we conducted the enzyme assays at this temperature so that we could analyze 
297 enzyme activity under physiologically relevant conditions. The resulting specific enzyme activities 
298 are shown in Table 2. 
299 As depicted in Table 2, the overexpression of the E. cloacae-derived budAB operon lead to negligible 
300 activity of BudAB at 0.3 ± 0.2 U/mg, compared to 0.6 ± 0.3 U/mg for the control. The background 
301 enzyme activity observed in the control MGA3 pBV2xp strain is most probably due to spontaneous 
302 decarboxylation of acetolactate, that accumulates due to activity of native acetolactate synthase 
303 encoded by ilvH and ilvB, to acetoin. 53 Overexpression of alsSD operons derived from B. subtilis and 
304 B. licheniformis led to enzyme activity at levels of 11.3 ± 2.3 and 4.8 ± 1.7 U/mg, respectively. 
305 Comparison of the specific enzyme activities of the MGA3 acetBs strain to that observed for 
306 acetolactate synthase overexpressed in B. subtilis, shows similar activity levels with specific enzyme 










































































307 activities in cell extracts of B. subtilis at 6.2 ±0.5 U/mg measured at 37 °C. 56 The coupled enzyme 
308 activity in the MGA3 acetBs strain was 2.3-fold higher in comparison to MGA3 acetBl, despite the fact 
309 that the donor organism is mesophilic. B. licheniformis is known to be able to grow at higher 
310 temperatures in comparison to B. subtilis, with optimal growth temperatures around 50 °C. For that 
311 reason, our initial expectation was that MGA acetBl strain would perform better than the other 
312 strains tested. However, a study by Sommer et al. (2015) revealed that the optimal temperature for 
313 activity of acetolactate synthase AlsS from B. subtilis is 50 °C, making it an ideal candidate for use in 
314 MGA3. 57 Contrarily, for the acetolactate synthase BudB in E. cloacae and AlsS in B. licheniformis the 
315 optimal temperature has been found to be 37 °C. 58,59 No comparable data is available for the second 
316 enzyme of the pathway, acetolactate decarboxylase (AlsD), but our results indicate that AlsD from 
317 B. subtilis retains activity at 50 °C.
318 MGA3 acetBs, MGA3 acetBl and MGA3 acetEc were then tested for the production of acetoin. Fresh 
319 minimal medium with 200 mM methanol was inoculated with overnight cultures and the strains 
320 were allowed to grow for approximately 24 hours after induction. Cleared supernatant was sampled 
321 from the culture at the end of the experiment, which was then analyzed by RP-HPLC for acetoin 
322 titers. The measured acetoin concentrations for strains MGA3 pBV2xp, MGA3 acetBs, MGA3 acetBl 
323 and MGA3 acetEc are shown in Table 2. The best producer among the strains tested was MGA3 acetBs, 
324 with a final titer of 0.26 ± 0.04 g/L acetoin from 6.4 g/L methanol which is consistent with the 
325 enzyme assay results and corresponds to 0.04 g/g of methanol (Table 2). The R configuration of the 
326 produced acetoin can be assigned based on previous characterization of the acetolactate 
327 decarboxylase from B. subtilis used in this study which has been shown to be enantioselective for 
328 (R)-acetoin synthesis. 9The second-best producer among the strains tested was MGA3 acetBl with a 
329 titer at a level of 0.08 ± 0.02 g/L, which is 3.5-fold lower in comparison to MGA3 acetBs and in 
330 accordance with the previously observed enzyme activities (Table 2). Finally, MGA3 acetEc resulted 
331 in acetoin titers comparable to the empty vector control, MGA3 pBV2xp, indicating that the acetoin 
332 production pathway was likely inactive in vivo, an observation which is supported by the 
333 corresponding enzyme activity in Table 2. As depicted in Table 2, the best producer, MGA3 acetBs 
334 exhibited a reduced growth rate compared to the other strains in the first hours of growth and 
335 slowed down significantly 6 hours after induction to a specific growth rate of 0.07 h-1 (data not 
336 shown). The three remaining strains showed similar growth rates to each other. 










































































337 The acetoin titers achieved by the MGA3 acetBs strain are lower than titers achieved for acetoin 
338 producers where no metabolic engineering for substrate availability or co-factor regeneration was 
339 executed. It was shown that the thermotolerant B. subtilis IPE5-4 is able to produce up to 12.55 ± 
340 0.28 g/L acetoin in 72-hour shake flask fermentation at 50 °C in LB medium supplemented with 
341 100 g/L glucose as a carbon source, resulting in a yield of 0.13 g/g glucose. 14 The wild type 
342 B. licheniformis WX-02 strain produces 10.33 ± 0.02 g/L acetoin, along with 18.77 ± 0.33 g/L meso-
343 2,3-butanediol and 12.51 ± 0.36 g/L D-2,3-butanediol after 24 hours at 37 °C using 120 g/L glucose 
344 and 33 g/L of corn steep liquor in flask cultivation (yield of 0.12 g/g glucose). 60 Wild type E. cloacae 
345 SDM produces 2.72 ± 1.13 g/L of acetoin together with 40.30 ± 0.89 g/L of 2,3-butanediol (BD) in 
346 shake flask cultivations in minimal medium supplemented with 90.0 g/L glucose and 5.0 g/L yeast 
347 extract. Deletion of the budC gene in that strain, coding for acetoin reductase which catalyses the 
348 conversion of acetoin to 2,3-butanediol, lead to increased accumulation of acetoin at a level of 27.61 
349 ± 0.92 g/L, with a final yield of 0.3 g/g glucose. 61 Furthermore, E. coli engineered for acetoin 
350 production by heterologous overexpression of budRAB genes from S. marcescens H30 accumulated 
351 9.8 g/L of acetoin in batch fermentation in minimal medium supplemented with 60 g/L glucose, 
352 10 g/L of yeast extract and 2 g/L of sodium acetate which corresponds to a yield of 0.13 g/g glucose. 
353 62 However, several points need to be made regarding this comparison. Firstly, in our experiment a 
354 defined medium was used, whereas other strains were cultivated on glucose supplemented with 
355 additional complex media components such as yeast extract, tryptone and corn steep liquor. 
356 Secondly, in our production system, methanol was used as the C-source, which has not been 
357 achieved ever before in the case of acetoin production. For this reason, we believe that we have 
358 created a promising system for methanol-based acetoin production, and we have taken further 
359 steps to improve our production strain. 
360 To examine the regulation of the alsSDBs operon under the control of the xylose inducible promoter 
361 (xp), we also compared the coupled AlsS and AlsD enzyme activities in MGA3 acetBs and MGA3 
362 pBV2xp crude extracts upon induction with 10 g/L xylose and without induction. Crude extracts 
363 from MGA3 acetBs cells induced with 10 g/L xylose showed 22-fold higher enzyme activity 
364 compared to uninduced MGA3 acetBs cells. Furthermore, the AlsSD activity in uninduced MGA3 
365 acetBs is comparable to the enzyme activity of the empty vector control confirming that the system 
366 is tightly regulated. The results of this experiment are shown in Figure 3. We do not have an 










































































367 immediate explanation for the discrepancies observed in enzyme activity between the two separate 
368 experiments (Table 2 and Figure 3).
369 We examined the effect of different induction levels in order to analyze the functionality of the 
370 xylose inducible promoter. MGA3 acetBs, the strain that was chosen as the best producer based on 
371 the enzyme assay and production data was grown in minimal medium with 200 mM methanol and 
372 induced with different concentrations of D-(+)-xylose. We found that the optimal inducer 
373 concentration was the previously used 10 g/L. Xylose has previously been tested as a carbon source 
374 in B. methanolicus MGA3, and is metabolized by B. methanolicus but it is not able to support growth. 
375 35,63 More importantly, we found that the xp promoter was tightly controlled as almost no acetoin 
376 accumulation was observed when no xylose was added (Table 3). This is a beneficial feature of the 
377 expression system that can be used in cultivation schemes where growth is decoupled from 
378 production of target compounds and high cell densities are reached before induction of gene 
379 expression, avoiding the toxic effects and metabolic burden of acetoin production during biomass 
380 accumulation. Thus, concerns about acetoin toxicity at higher concentrations can be circumvented 
381 by use of the inducible promoter. 
382 We investigated acetoin accumulation in the growth medium over the course of the cultivation for 
383 the best producing strain MGA3 acetBs. Supernatants were collected every 2 hours for the first 8 
384 hours after induction, followed a final sample 21.5 hours after inoculation. As shown in Figure 4, the 
385 acetoin was accumulated in a manner proportional to the growth pattern over the course of first 6 
386 hours after induction, which indicates that acetoin production is coupled to biomass formation, and 
387 that its production starts soon after induction with 10 g/L xylose.
388 Furthermore, we have analyzed the formation of by-products in MGA3 acetBs in order to investigate 
389 putative targets for pathway optimization (Table 4). We have focused on accumulation of amino 
390 acids in the cultivation medium, because L-glutamate is known to be one of the main products of the 
391 overflow metabolism in B. methanolicus and L-alanine is synthetized directly from pyruvate, which 
392 means that its production directly competes with acetoin biosynthesis. 64,65 The L-alanine titer was 
393 not affected in the acetoin producing strain MGA3 acetBs. Surprisingly the L-glutamate titer 
394 increased from 0.01 ± 0.00 g/L in the empty vector control to 0.02 ± 0.00 g/L in the MGA3 acetBs 
395 strain, although the acetoin titer was more than tenfold higher (Table 4). For this reason, we focused 
396 our next step on replenishing the pyruvate pool from the tricarboxylic acid (TCA) cycle.










































































397 Influence of overproduction of pyruvate replenishing enzymes on acetoin accumulation 
398 Pyruvate, being one of the metabolites which belong to the central carbon metabolism, is formed 
399 from methanol via the ribulose monophosphate (RuMP) cycle (Figure 1). It can either enter the TCA 
400 cycle for oxidation to CO2 or be used as biosynthetic precursor to f. ex. L-alanine or for the product 
401 acetoin. For this reason, to increase the titers of acetoin in B. methanolicus MGA3 from methanol, 
402 we decided to increase the pyruvate availability in B. methanolicus MGA3 acetBs by overexpressing 
403 genes coding for enzymes involved in pyruvate generating reactions. Using similar criteria to those 
404 previously described, five candidates were selected for testing; malic enzyme (encoded by maeBl) 
405 from Bacillus licheniformis, malic enzyme (encoded by maeGs) from Geobacillus stearothermophilus, 
406 pyruvate kinase (encoded by pykBm) and phosphoenolpyruvate carboxykinase (encoded by pckABm) 
407 from B. methanolicus and oxaloacetate decarboxylase (encoded by odxCg) from Corynebacterium 
408 glutamicum, and oxaloacetate decarboxylase (encoded by citMLl) from Lactococcus lactis. It was 
409 shown before that the optimum temperature for malic enzyme from G. stearothermophilus is 55 °C, 
410 which makes it a suitable target for use in the thermophilic B. methanolicus; furthermore it shares 
411 48% identity with the YtsJ from B. subtilis which performs the major physiological role of the four 
412 paralogous malic enzyme isoforms in Bacillus subtilis. 66,67 Additionally, a B. licheniformis-derived 
413 malic enzyme was chosen as a suitable target because of its high similarity (80% identity) to 
414 B. subtilis-derived, ywkA- encoded malic enzyme which belongs to other subgroup of malic enzymes 
415 in B. subtilis than YtsJ. 68 Both C. glutamicum-derived odx and L. lactis-derived citM were 
416 characterized to code for functional oxaloacetate decarboxylases (OAD). The L. lactis-derived 
417 oxaloacetate decarboxylase exhibits optimal activity at 50 °C and the one derived from 
418 C. glutamicum was only assayed at 22°C, however no test for the optimum temperature has been 
419 performed. 69,70 Lastly, the transcripts of pykBm coding for pyruvate kinase and pckABm coding for 
420 phosphoenolpyruvate carboxykinase were found in the whole transcriptome study of 
421 B. methanolicus MGA3 indicating that these two genes are transcribed. 36 Additionally, Pyk was 
422 present in the proteome of B. methanolicus signifying that it is produced in this bacterium. 71 
423 The genes were cloned into a rolling circle plasmid, pTH1mp (or, in the case of citMLl, pMI2; the only 
424 difference between pTH1mp and pMI2mp being copy number in E. coli), under the control of the 
425 methanol dehydrogenase promoter (mp) from B. methanolicus MGA3. Competent B. methanolicus 
426 MGA3 acetBs cells were transformed with these plasmids, and cultured for 25 hours, after which 










































































427 culture broth samples were collected. Cleared samples were analyzed by RP-HPLC to quantify 
428 acetoin concentrations. 
429 Table 5 presents the acetoin titers of B. methanolicus MGA3 acetBs strains producing pyruvate 
430 replenishing enzymes. The acetoin titer for the control strain MGA3 acetBs + pTH1mp was 0.31 ± 
431 0.01 g/L, which was 20 % higher in comparison to the parent strain acetBs, despite the expected 
432 metabolic burden of carrying the second plasmid. As shown in Table 5, acetoin titers were only 
433 improved for MGA3 acetBs + pyrCg in comparison to the control strain MGA3 acetBs + pTH1mp, 
434 resulting in an increase of acetoin concentration by approximately 13 %, from 0.31 ± 0.01 g/L to 
435 0.35 ± 0.02 g/L. The fact that overproduction of C. glutamicum-derived OAD led to an increase of 
436 acetoin accumulation while overproduction of the L. lactis-derived OAD did not may be caused by 
437 the low pH optimum of the latter. 69 It has been shown before that enzymes with an optimal pH 
438 below 5 are functional in B. methanolicus only to a limited extent. 33 
439 Comparison of growth curves of the B. methanolicus MGA3 strains during acetoin production 
440 revealed that the best producer, MGA3 acetBs + pyrCg, had a prolonged lag-phase during the main 
441 cultivation (Figure S2, supplementary information). However, it is unlikely that this influenced the 
442 final acetoin titers. The rest of the strains seemed to follow very similar growth patterns with 
443 exponential and stationary growth phases, followed by cell lysis.
444 Effect of glyoxylate shunt overexpression on acetoin production
445 To further improve the acetoin titer in B. methanolicus MGA3 we investigated the effect of 
446 overexpressing genes coding for enzymes involved in the native glyoxylate shunt from 
447 B. methanolicus MGA3. It is shown in Table 5 that overexpression of some of the genes coding for 
448 pyruvate producing enzymes had a positive effect on acetoin titers, and we wanted to investigate if 
449 coupling one of these reactions to an overexpressed glyoxylate shunt pathway would further 
450 improve acetoin titers. The glyoxylate shunt genes in MGA3 have been annotated, but their 
451 functionality has not yet been tested. Genetic complementation of C. glutamicum ΔaceAB deletion 
452 mutants by heterologous overexpression of aceBABm demonstrated the functionality of the 
453 B. methanolicus MGA3 gloxylate shunt genes in vivo (Figure 5). In cultures with potassium acetate 
454 as the sole carbon source the complemented strain reached a higher OD600 (Figure 5B, 7.4 ± 0.2) 
455 than the empty vector control (Figure 5C, 1.5 ± 0.2) indicating more biomass formation and 
456 improved acetate utilization.










































































457 Moreover, functional overproduction of endogenous AceABm was confirmed by an in vitro enzyme 
458 assay (Figure 6). Specific activities of isocitrate lyase in crude extracts of overexpression strains 
459 were significantly higher compared to the native crude extract background activity. The specific 
460 activities of both empty vector and full vector samples increased when temperature was increased 
461 from 30 °C to 50 °C as expected from Arrhenius law. Thus, homologous overexpression of the 
462 glyoxylate shunt genes should aid in precursor supply for acetoin production.
463 Even though no difference was observed in acetoin accumulation between the control strain MGA3 
464 acetBs + pTH1mp and MGA3 acetBs + pyrGs, we chose the latter as the target for further genetic 
465 modifications because we wanted to use a strain which utilized malate directly for pyruvate 
466 generation, instead of oxaloacetate. The isocitrate lyase (aceA) gene from B. methanolicus was 
467 cloned into pTH1mp-maeGs and used for transformation of competent MGA3 acetBs cells. The 
468 resulting strain, MGA3 acetBs + glyoxBm was cultivated for acetoin production as described before 
469 alongside MGA3 acetBs + pTH1mp and MGA3 acetBs + pyrGs. The acetoin concentration is depicted in 
470 Figure 7 with growth patterns of the strains shown in Figure S2 (supplementary information).
471 As shown in Figure 7 the additional overexpression of the aceA gene from B. methanolicus MGA3 
472 together with maeGs on the pTH1mp plasmid (glyoxBm) had a significant impact on acetoin titers with 
473 an increase of 33 % in comparison to MGA3 acetBs + pTH1mp. Surprisingly, despite increased 
474 acetoin accumulation by the MGA3 acetBs + glyoxBm strain in comparison to MGA3 acetBs + pyrGs and 
475 MGA3 acetBs + pTH1mp, no major difference in growth patterns between the strains was observed 
476 (Figure S3, supplementary information). 
477 We showed that metabolic engineering aimed at increasing pyruvate availability for conversion to 
478 acetoin in MGA3 improved acetoin titers, from 0.31 ± 0.01 g/L (MGA3 acetBs + pTH1mp) to 0.35 ± 
479 0.02 g/L (MGA3 acetBs + pyrCg) and to 0.42 g/L (MGA3 acetBs + glyoxBm). Increasing pyruvate 
480 availability should exert a metabolic “push” effect on the acetolactate synthase reaction, thereby 
481 increasing the rate of conversion. At the same time, previous studies have shown that in MGA3 the 
482 activity of pyruvate carboxylase encoded by pyc, converting pyruvate to oxaloacetate, is in a much 
483 lower range (nM/min) in comparison to our heterologously produced AlsSD enzymes (µM/min). 42 
484 The combined overexpression of the gene coding for malic enzyme from G. stearothermophilus and 
485 the aceA gene from MGA3 resulted in significantly increased acetoin titers in comparison to MGA3 










































































486 acetBs + pTH1mp. Together, these two enzymes provide a path from isocitrate to pyruvate, 
487 bypassing large parts of the citric acid cycle. 
488 Manipulation of carbon flux through precursor supply reactions has received attention due to its 
489 potential to significantly change precursor pools in metabolite overproduction processes. 72 In 
490 particular, the “phosphoenolpyruvate-pyruvate-oxaloacetate node” has been highlighted as a 
491 critical target for metabolic engineering, and was extensively covered by Sauer and Eikmanns 
492 (2005). 73 Evidence for the impact of increased pyruvate availability on acetoin production was 
493 shown when Nielsen et al. (2010) improved acetoin titers in E. coli by increasing intracellular 
494 pyruvate availability through extensive metabolic engineering. 74 
495 The titers achieved in this study are lower than in sugar-based acetoin production bioprocesses. It has to 
496 be noted that production of acetoin from methanol requires C-C bond formation (here in the RuMP cycle) 
497 whereas its production from glucose or other sugars does not. The titer of 0.42 g/L of acetoin produced 
498 solely from the one carbon feedstock methanol is comparable to titers reached for other products when one 
499 carbon raw materials were used. Methylomicrobium buryatense was engineered for microbial conversion of 
500 methane to lactate with initial titers of 0.06 g/L in 0.5 L bioreactors, improved to 0.8 g/L of lactate in a 5 L 
501 tank bioreactor (0.05 g/g yield). 75 Recombinant Clostridium ljungdahlii produced 0.07 g/L of butyrate from 
502 syngas, and metabolically engineered Methylobacterium extorquens produced 0.08 g/L α-humulene from 
503 methanol in shake flasks, which was further increased to 1.6 g/L in a fed-batch bioreactor (0.031 g/g yield). 
504 76,77 The recombinant Acetobacterium woodii produced 0.87 g/L of acetone from CO2 in bottle fermentation 
505 (0.07 g/g yield), which was enhanced to 3.02 g/L in continuous fermentation (0.03 g/g yield). 78 Metabolic 
506 engineering of Methylobacterium rhodesianum lead to production of 0.36 g/L of (R)-3-hydroxybutyrate in 
507 batch cultures (0.036 g/g yield) and 2.8 g/L in fed-batch cultures (0.009 g/g yield) from methanol. 79 In all 
508 these examples, the titers in small scale batch cultivations were either one order of magnitude lower or in 
509 the same range as those achieved in our study. Recently, production of acetoin from an H2/CO2 gas mixture 
510 was achieved for engineered Cupriavidus necator with a titer of 1.2 g/L in a 55-hour 1L-Schott bottle 
511 cultivation and 3.9 g/L in 14-day continuous gas flow fermentation. 80 These titers were achieved in a 
512 fermentation over a longer time period and in a bigger scale than our bioprocess which demonstrated a 
513 potential for future enhancements of C1-based production of acetoin. 
514 With future optimizations in strain genetics and fermentation conditions it is plausible that methanol-based 
515 acetoin production can be cost competitive with sucrose-based acetoin production. It is worth noting that 










































































516 the pathway yield (YP) for action production from methanol and glucose are very similar, 0.46 g/g and 0.49 
517 g/g, respectively, and with our current yield of 0.07 g acetoin/g methanol there is a great potential for future 
518 developments. 81 As a comparison, the highest yield (R)-acetoin bioprocess from glucose reported a yield of 
519 0.47 g/g, while the highest (R)-acetoin titers recorded from glucose reached a yield of 0.36 g/g. 82,83  It seems 
520 that one of the most limiting factors for acetoin production is NADH accumulation. The majority of reduction 
521 potential in MGA3 is formed during methanol assimilation and formaldehyde oxidation, resulting in 1 mol 
522 NADH for every mol methanol assimilated, and 1 additional mol of both NADH and NADPH for every mol of 
523 formaldehyde oxidized. 42 During growth on methanol the citric acid cycle is therefore not critical for the 
524 generation of reduction potential, but in combination with anaplerotic reactions provides intermediates for 
525 amino acid synthesis and other coupled processes. Wildtype MGA3 has previously been shown to 
526 overproduce and secrete glutamate, which likely explains why redirection of the metabolic flux from the 
527 TCA cycle to acetoin production could result in significantly improved acetoin titers. 84 In the reaction 
528 catalyzed by glutamate dehydrogenase, which in B. methanolicus has a key role in L-glutamate synthesis, 
529 one mol of NADH is oxidized for every mol of glutamate synthesized, making it an important player in 
530 maintaining the redox balance in B. methanolicus MGA3. 65 It is therefore likely that strategies where acetoin 
531 titers are increased at the expense of glutamate would need to involve metabolic engineering to maintain 
532 redox balance, similar to that shown by Liu et al. (2017) for increased acetoin titers from glucose in 
533 Lactococcus lactis. 85 
534 Feasibility of methanol-based acetoin production
535 There are several points to be made that speak in favor of methanol as a replacement of sugar as 
536 feedstock, even though the current titers in our methanol-based approach are lower than titers 
537 achieved in sugar-based systems. The main advantage of methanol-based acetoin production is the 
538 decoupling of production costs from the global sugar market, which can be influenced by external 
539 environmental factors such as heat waves and other extreme weather events, an issue which is 
540 forecasted to increase in severity in the coming decades. 86–88 Methanol can be produced from 
541 natural gas or fermentation of waste biomass by steam reformation of methane, making its 
542 production less cost vulnerable to these factors. 89 In the last reported quarter of 2019, the average 
543 methanol spot price for Europe as announced by the Methanol Institute, a trade association for 
544 methanol producers , was €288/metric ton. 90 With the best acetoin yield presented in this paper, 
545 this puts the methanol cost per kg acetoin at €4.38 for our method compared to feedstock costs at 










































































546 €0.81-0.86/kg acetoin using sugar. 7,8,91 This means that our methanol-based bioprocess is currently 
547 more expensive with regards to feedstock costs, but a 5-fold improvement to titers of 2 g/L would 
548 abolish this discrepancy. Additionally, it is worth mentioning that methanol-based bioprocesses 
549 have several advantages over sugar-based processes, such as a reduced demand for complex 
550 nutrients in methanol-based processes compared to sugar-based ones resulting in decreased costs 
551 of the production medium and a decrease of the downstream processing cost, which can contribute 
552 to more than 50 % of the production costs in conventional bioprocesses. 17
553 Conclusions
554 Here, a method for production of acetoin from methanol with the use of the thermophilic Bacillus 
555 methanolicus MGA3 has been developed for the first time. Until now, only plant-biomass based 
556 carbon sources such as glucose, xylose, cellulose, hemicellulose and seaweed have been used to 
557 produce acetoin, a valuable platform chemical. Here, a natural methylotroph, Bacillus methanolicus 
558 MGA3, was used to overexpress B. subtilis - derived genes coding for an acetoin production pathway, 
559 yielding a strain producing up to 0.26 g/L acetoin from 6.4 g/L methanol. The engineered acetoin 
560 producing MGA3 strain was further improved through bypassing parts of the TCA cycle by 
561 overproduction of isocitrate lyase together with malic enzyme. Employment of this strategy led to 
562 development of a strain producing 0.42 g/L of acetoin in batch experiments (0.07 g/g methanol). 
563 This work helps pave an unprecedented path for production of valuable platform chemicals from 
564 methanol. 
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730 Table 1 Bacterial strains, plasmids and used in this study.
Strain name Relevant characteristics Reference
E. coli DH5α General cloning host, F-thi-1 endA1 hsdR17(r-,m-) supE44 _lacU169 
(_80lacZ_M15) recA1 gyrA96 relA1
Stratagene
B. methanolicus MGA3 Wild type strain ATCC 53907
B. subtilis 168 Wild type strain ATCC 23857
B. licheniformis MW3 Bacillus licheniformis DSM13 (ΔhsdR1, ΔhsdR2) Waschkau et al. (2008) 92
C. glutamicum ATCC 13032 Wild type strain ATCC 13032
C. glutamicum MH20-22b Lysine-producing Leu- derivative of ATCC13032 Schrumpf et al. (1992) 93
C. glutamicum MH20-22b ΔaceAB MH20-22b derivative with an aceAB deletion Wendisch (1997) 94
G. stearothermophilus 10 Wild type strain ATCC 12980
Lactococcus lactis ssp. lactis IL1403 Wild type strain Bolotin et al. (2001) 95
Abbreviation Plasmid name Relevant characteristics Reference
pTH1mp pTH1mp CmR; derivative of pTH1mp-lysC for gene expression under control 
of the mdh promoter. The lysC gene was replaced with multiple 
cloning site. 
Irla et al. (2016) 35
pTH1xp pTH1xp CmR; E. coli/Bacillus spp. shuttle vector for gene expression under 
control of the inducible xylose promoter from B. megaterium. 
Irla et al. (2016) 35
pMI2mp pMI2mp CmR; low copy derivative (in E. coli) of pTH1mp This study
pBV2mp pBV2mp KanR; pHCMC04 derivative, gene expression under control of the 
mdh promoter, theta replicating
Irla et al. (2016) 35
pBV2xp pBV2xp KanR; pHCMC04 derivative, gene expression under the control of 
the inducible xylose promoter from B. megaterium, theta 
replicating
This study










































































pEC-XT99A pEC-XT99A TetR; C. glutamicum / E. coli shuttle vector under control of the trc 
promoter. Based on the medium copy number plasmid pGA1.
Kirchner and Tauch (2003) 96
pET-RABC pET-RABC KanR; pET28a carrying 2,3-BD gene cluster with its operon 
originated from Enterobacter cloacae subsp. dissolvens SDM
Xu et al. (2014) 97 
acetBs pBV2xp-alsSDBs KanR; pBV2xp derivative for expression of alsSD operon from B. 
subtilis under control of xylose inducible promoter xp
This study
acetBl pBV2xp-alsSDBl KanR; pBV2xp derivative for expression of budA-alsD operon from 
B. licheniformis under control of xylose inducible promoter xp
This study
acetEc pBV2xp-budABEc KanR; pBV2xp derivative for expression of budAB operon from 
Enterobacter cloacae under control of xylose inducible promoter xp
This study
pyrCg pTH1mp-odxCg CmR; pTH1mp derivative for expression of odx from C. glutamicum 
ATCC 13032 under control of the mdh promoter 
This study
pyrLl pMI2mp-citMLl CmR; pTH1mp derivative for expression of citM from Lactococcus 
lactis IL1403under control of the mdh promoter 
This study
pyrGs pTH1mp-maeGs CmR; pTH1mp derivative for expression of maeGs from Geobacillus 
stearothermophilus 10 under control of the mdh promoter 
This study
pyrBl pTH1mp-maeBl CmR; pTH1mp derivative for expression of maeBl from Bacillus 
licheniformis MW3 under control of the mdh promoter
This study
pyrBm pTH1mp-pckA-pyk CmR; pTH1mp derivative for expression of B. methanolicus-derived 
pckA and pyk under control of the mdh promoter
This study
glyoxBm pTH1mp-maeGs-aceA CmR; pTH1mp derivative for expression of maeGs from Geobacillus 
stearothermophilus 10 and B. methanolicus-derived aceA under 
control of the mdh promoter
This study
pBV2xp-aceBA pBV2xp-aceBA KanR; pBV2xp derivative for expression of aceBA operon from B. 
methanolicus under control of xylose inducible promoter xp
This study
pEC-XT99A-aceBA pEC-XT99A-aceBA TetR; pEC-XT99A derivative for expression of aceBA operon from B. 
methanolicus under control of IPTG inducible promoter trc
This study










































































732 Table 2 Specific enzyme activity, acetoin final titers and specific growth rates for MGA3 acetoin production 
733 strains. The means of triplicates with standard deviations are shown.
Strain name Coupled AlsSD activity 
[U/mg protein]
Acetoin titer [g/L] Specific growth rate, µ 
[h-1]
MGA3 pBV2xp 0.56 ± 0.32 0.01 ± 0.00 0.27
MGA3 acetBs 11.28 ± 2.28 0.26 ± 0.04 0.22
MGA3 acetBl 4.75 ± 1.68 0.09 ± 0.03 0.29
MGA3 acetEc 0.39 ± 0.17 0.03 ± 0.00 0.30
734
735 Table 3 Effect of different inducer concentrations on final acetoin titers in MGA3 acetBs. The strain was 
736 grown in minimal medium with 200 mM methanol and induced with different concentrations of xylose 
737 added to the growth medium two hours after inoculation. The means of triplicates with standard deviations 
738 are shown.
Xylose concentration [g/L] 0.0 0.5 1.0 5.0 10.0 20.0
Acetoin titer [g/L] 0.00 ± 0.00 0.12 ± 0.00 0.14 ± 0.00 0.15 ± 0.01 0.15 ± 0.01 0.14 ± 0.01
739
740 Table 4 Final titers of acetoin, L-glutamate and L-alanine for MGA3 acetBs. The means of triplicates with 
741 standard deviations are shown.
Strain name Acetoin titer [g/L] L-glutamate titer [g/L] L-alanine titer [g/L]
MGA3 pBV2xp 0.01 ± 0.00 0.01 ± 0.00 0.04 ± 0.00
MGA3 acetBs 0.26 ± 0.04 0.02 ± 0.00 0.04 ± 0.00
742
743 Table 5 Acetoin titers in B. methanolicus MGA3 acetBs strains with a second plasmid overexpressing 
744 pyruvate replenishing genes. The strains were grown in minimal medium with 200 mM methanol and 
745 induced with 10 g/L of xylose added to the growth medium two hours after inoculation. The concentration 
746 of acetoin was measured 25 h after inoculation. The means of triplicates with standard deviations are 
747 shown.
Strain Acetoin concentration [g/L]
MGA3 acetᴮˢ + pTH1mp 0.31 ± 0.01
MGA3 acetᴮˢ + pyrᴸˡ 0.30 ± 0.02
MGA3 acetᴮˢ + pyrᴳˢ 0.29 ± 0.03
MGA3 acetᴮˢ + pyrᴮˡ 0.32 ± 0.01
MGA3 acetᴮˢ + pyrCᵍ 0.35 ± 0.02
MGA3 acetᴮˢ + pyrᴮᵐ 0.33 ± 0.02
748
749












































































752 Figure 1 a) Overview of heterologously expressed genes and their metabolic functions in this study. The 
753 dotted arrows represent chain of more than one enzymatic reaction, solid lines represent one enzymatic 
754 reaction. Gene names coding for enzymes catalyzing relevant reactions are depicted in the graph. 
755 Abbreviations: mae - malic enzyme gene, pyk - pyruvate kinase gene, pckA - phosphoenolpyruvate 
756 carboxykinase gene, odx - oxaloacetate decarboxylase gene, alsS - acetolactate synthase gene, alsD - 
757 acetolactate decarboxylase gene, aceA - isocitrate lyase gene, RuMP cycle - ribulose monophosphate (RuMP) 
758 cycle. b) Metabolic pathway from pyruvate to acetoin showing stereochemistry for intermediate and end 
759 products. 
760
761 Figure 2 Growth rates of B. methanolicus MGA3 cultivated in minimal medium supplemented with 200 mM 
762 methanol and with increasing concentrations of acetoin. IC50 of acetoin in B. methanolicus was determined 
763 to be 26 g/L (293 mM). The means of triplicates with standard deviations are shown.
764
765 Figure 3 Coupled AlsSD specific enzyme activities with and without induction of the xp promoter by 10 g/L 
766 xylose. MGA3 acetBs was selected for this experiment because it displayed the highest activities previously. 
767 MGA3 pBV2xp was used as a negative control. The means of triplicates with standard deviations are shown.
768
769 Figure 4 Acetoin accumulation in the growth medium and OD600 over time for MGA3 acetBs. The strain was 
770 grown in minimal medium with 200 mM methanol and induced with 10 g/L of xylose added to the growth 
771 medium two hours after inoculation. The concentration of acetoin and OD600 were monitored every 2 hours 
772 over a period of 8 hours and at time 21.5 h after inoculation. The means of triplicates with standard 
773 deviations are shown.
774
775 Figure 5 Complementation of C. glutamicum ΔaceAB with B. methanolicus MGA3 genes. ΔOD600 of strains 
776 MH20-22b(pEC-XT99A) a) MH20-22B ΔaceAB(pEC-XT99A; b) MH20-22B ΔaceAB(pEC-XT99A-aceBABm); c) 
777 after growth with glucose (gluc) and/or potassium acetate (KAc). The means of triplicates with standard 
778 deviations are shown.
779
780 Figure 6 In vitro isocitrate lyase specific activity in B. methanolicus MGA3 crude extracts at 30°C and 50°C. 
781 The means of triplicates with standard deviations are shown.
782
783 Figure 7 Acetoin production in MGA3 acetBs strain with overexpressed genes coding for the glyoxylate 
784 shunt pathway compared to control strains. The strains were grown in minimal medium with 200 mM 
785 methanol and induced with 10 g/L of xylose added to the growth medium two hours after inoculation. The 
786 concentration of acetoin was measured at time 25 h after inoculation. The means of triplicates with 
787 standard deviations are shown.
788










































































Figure 1 a) Overview of heterologously expressed genes and their metabolic functions in this study. The 
dotted arrows represent chain of more than one enzymatic reaction, solid lines represent one enzymatic 
reaction. Gene names coding for enzymes catalyzing relevant reactions are depicted in the graph. 
Abbreviations: mae - malic enzyme gene, pyk - pyruvate kinase gene, pckA - phosphoenolpyruvate 
carboxykinase gene, odx - oxaloacetate decarboxylase gene, alsS - acetolactate synthase gene, alsD - 
acetolactate decarboxylase gene, aceA - isocitrate lyase gene, RuMP cycle - ribulose monophosphate (RuMP) 
cycle. b) Metabolic pathway from pyruvate to acetoin showing stereochemistry for intermediate and end 
products. 
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Figure 2 Growth rates of B. methanolicus MGA3 cultivated in minimal medium supplemented with 200 mM 
methanol and with increasing concentrations of acetoin. IC50 of acetoin in B. methanolicus was determined 
to be 26 g/L (293 mM). The means of triplicates with standard deviations are shown. 
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Figure 3 Coupled AlsSD specific enzyme activities with and without induction of the xp promoter by 10 g/L 
xylose. MGA3 acetBs was selected for this experiment because it displayed the highest activities previously. 
MGA3 pBV2xp was used as a negative control. The means of triplicates with standard deviations are shown. 
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Figure 4 Acetoin accumulation in the growth medium and OD600 over time for MGA3 acetBs. The strain was 
grown in minimal medium with 200 mM methanol and induced with 10 g/L of xylose added to the growth 
medium two hours after inoculation. The concentration of acetoin and OD600 were monitored every 2 hours 
over a period of 8 hours and at time 21.5 h after inoculation. The means of triplicates with standard 
deviations are shown. 
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Figure 5 Complementation of C. glutamicum ΔaceAB with B. methanolicus MGA3 genes. ΔOD600 of strains 
MH20-22b(pEC-XT99A) a) MH20-22B ΔaceAB(pEC-XT99A); b) MH20-22B ΔaceAB(pEC-XT99A-aceBABm); c) 
after growth with glucose (gluc) and/or potassium acetate (KAc). The means of triplicates with standard 
deviations are shown. 
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Figure 6 In vitro isocitrate lyase specific activity in B. methanolicus MGA3 crude extracts at 30°C and 50°C. 
The means of triplicates with standard deviations are shown. 
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Figure 7 Acetoin production in MGA3 acetBs strain with overexpressed genes coding for the glyoxylate shunt 
pathway compared to control strains. The strains were grown in minimal medium with 200 mM methanol 
and induced with 10 g/L of xylose added to the growth medium two hours after inoculation. The 
concentration of acetoin was measured at time 25 h after inoculation. The means of triplicates with standard 
deviations are shown. 
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